NanoWisa - a technology for cancer treatment kort fortalt

We have an approved US patent (see below) on a nanotechnology which can be used in cancer treatment to potentially cure cancer. The technology in a less advanced form is today used to treat tumors even tumors in pancreatic and liver cancers. Here in Denmark it is used at Rigshopitalet to treat patients for skin cancer.

The problem with the current technology is that plates, rods and needles are inserted deep inside the patients to achieve the electrical field gradients over the tumors that is necessary to kill them. Our technology is based on nanoparticles and a certain arrangement of them that ensures a very high electrical field gradient and thus can be used without inserting metal items inside the patients.

An investment of NOK 150 million is required to bring the project to clinical trial. Though passing several milestones and spread over several tranches with the option of drawing licenses along the way.

WhitePaper for NanoWisa

Ta del i prosjektet

Investér tid, penger, eller skap et partnerskap

Jeg vil investere! - Klikk her



Hva mener du?

InnoScore

4 / 10

Økonomi

kr 150 000 000

Venture capital (VC)

kr 300 000 000

Praktisk


Idé


Ikke oppgitt.

Hovedsamarbeidspartnere



Open Innovation Lab of Norway
NorBAN

Partnere


DNV GL
IKT Norge
Opera
Telenor

PWC
Investinor
Start Norge
Nofas

Simula
Seed Forum
Argentum
Partnership for Change

Mediepartnere


Hegnar Online
Ukeavisen Ledelse

Computerworld


InnoBørs - En samfunnsnyttig tjeneste levert av Innovate AS © 2018
Vi gjør for ordens skyld oppmerksom på at InnoBørs er en formidlingstjeneste, og ikke en reell børs i ordets rette forstand.

Design og drift: Mediamakeriet